Data / Form D filings / Thoclor US, Inc.
Thoclor US, Inc.: Form D filing
Thoclor US, Inc., a biotechnology company in Florham Park, NJ, filed a Form D with the SEC in 2026. The latest, on February 12, 2026, reports $225,000 sold of a $500,000 offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1 SHETLAND ROAD, Florham Park, NJ, 07932
- Phone
- (973) 224-7272
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2026
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2109348
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | New notice | $500,000 | $225,000 | $275,000 | 3 | Feb 4, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Tom Hadley | Executive Officer, Director | President and Chief Executive Officer |
| Hennie Roos | Director | |
| Stuart Russell | Director | |
| Tim Ayers | Director | |
| Mark Rattray | Executive Officer, Director | Chief Operating Officer |
Other biotechnology companies in New Jersey that filed recently
- Ensho Therapeutics, Inc. $7.3 million · Oct 15, 2026
- Xenon Ophthalmics Inc $3.3 million · Oct 6, 2026
- LISATA THERAPEUTICS, INC. $351.9 million · Oct 2, 2026
- Bullseye Biodevices, Inc. $1.3 million · Aug 10, 2026
- Hepion Pharmaceuticals, Inc. $3.1 million · Aug 5, 2026
Every Form D from the week of Feb 9, 2026 · All recent filings in New Jersey · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Thoclor US, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.